These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18322385)

  • 1. Investigating convergent actions of genes linked to familial Parkinson's disease.
    Wolozin B; Saha S; Guillily M; Ferree A; Riley M
    Neurodegener Dis; 2008; 5(3-4):182-5. PubMed ID: 18322385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans.
    Saha S; Guillily MD; Ferree A; Lanceta J; Chan D; Ghosh J; Hsu CH; Segal L; Raghavan K; Matsumoto K; Hisamoto N; Kuwahara T; Iwatsubo T; Moore L; Goldstein L; Cookson M; Wolozin B
    J Neurosci; 2009 Jul; 29(29):9210-8. PubMed ID: 19625511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Functional Assessment of LRRK2 in Caenorhabditis elegans Mechanosensory Neurons.
    Kuwahara T
    Methods Mol Biol; 2021; 2322():175-184. PubMed ID: 34043203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease.
    Yao C; El Khoury R; Wang W; Byrd TA; Pehek EA; Thacker C; Zhu X; Smith MA; Wilson-Delfosse AL; Chen SG
    Neurobiol Dis; 2010 Oct; 40(1):73-81. PubMed ID: 20382224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity.
    Yao C; Johnson WM; Gao Y; Wang W; Zhang J; Deak M; Alessi DR; Zhu X; Mieyal JJ; Roder H; Wilson-Delfosse AL; Chen SG
    Hum Mol Genet; 2013 Jan; 22(2):328-44. PubMed ID: 23065705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease.
    Di Domenico F; Sultana R; Ferree A; Smith K; Barone E; Perluigi M; Coccia R; Pierce W; Cai J; Mancuso C; Squillace R; Wiengele M; Dalle-Donne I; Wolozin B; Butterfield DA
    Antioxid Redox Signal; 2012 Dec; 17(11):1490-506. PubMed ID: 22315971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of physiologic actions of LRRK2: focus on autophagy.
    Ferree A; Guillily M; Li H; Smith K; Takashima A; Squillace R; Weigele M; Collins JJ; Wolozin B
    Neurodegener Dis; 2012; 10(1-4):238-41. PubMed ID: 22204929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants.
    Ilieva NM; Hoffman EK; Ghalib MA; Greenamyre JT; De Miranda BR
    Neurobiol Dis; 2024 Jun; 196():106522. PubMed ID: 38705492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A trojan horse for Parkinson's disease.
    Hu Y; Tong Y
    Sci Signal; 2010 Apr; 3(116):pe13. PubMed ID: 20371768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models.
    Liu Z; Hamamichi S; Lee BD; Yang D; Ray A; Caldwell GA; Caldwell KA; Dawson TM; Smith WW; Dawson VL
    Hum Mol Genet; 2011 Oct; 20(20):3933-42. PubMed ID: 21768216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the functional genomics of Parkinson's disease in Caenorhabditis elegans: LRRK2 and beyond.
    Chandler RJ; Cogo S; Lewis PA; Kevei E
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34397087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated LRRK2 signaling in response to endoplasmic reticulum stress leads to dopaminergic neuron degeneration in C. elegans.
    Yuan Y; Cao P; Smith MA; Kramp K; Huang Y; Hisamoto N; Matsumoto K; Hatzoglou M; Jin H; Feng Z
    PLoS One; 2011; 6(8):e22354. PubMed ID: 21857923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease.
    Tsika E; Nguyen AP; Dusonchet J; Colin P; Schneider BL; Moore DJ
    Neurobiol Dis; 2015 May; 77():49-61. PubMed ID: 25731749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity.
    Dusonchet J; Li H; Guillily M; Liu M; Stafa K; Derada Troletti C; Boon JY; Saha S; Glauser L; Mamais A; Citro A; Youmans KL; Liu L; Schneider BL; Aebischer P; Yue Z; Bandopadhyay R; Glicksman MA; Moore DJ; Collins JJ; Wolozin B
    Hum Mol Genet; 2014 Sep; 23(18):4887-905. PubMed ID: 24794857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease.
    Gandhi PN; Chen SG; Wilson-Delfosse AL
    J Neurosci Res; 2009 May; 87(6):1283-95. PubMed ID: 19025767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of TIR-1/SARM-1 by miR-71 Protects Dopaminergic Neurons in a
    Naidoo D; de Lencastre A
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2.
    Hsu CH; Chan D; Greggio E; Saha S; Guillily MD; Ferree A; Raghavan K; Shen GC; Segal L; Ryu H; Cookson MR; Wolozin B
    J Neurochem; 2010 Mar; 112(6):1593-604. PubMed ID: 20067578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features of LRRK2-associated Parkinson's disease].
    Pchelina SN; Ivanova ON; Emel'ianov AK; Iakimovskiĭ AF
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12):56-62. PubMed ID: 22433811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression.
    Reinhardt P; Schmid B; Burbulla LF; Schöndorf DC; Wagner L; Glatza M; Höing S; Hargus G; Heck SA; Dhingra A; Wu G; Müller S; Brockmann K; Kluba T; Maisel M; Krüger R; Berg D; Tsytsyura Y; Thiel CS; Psathaki OE; Klingauf J; Kuhlmann T; Klewin M; Müller H; Gasser T; Schöler HR; Sterneckert J
    Cell Stem Cell; 2013 Mar; 12(3):354-67. PubMed ID: 23472874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
    Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
    Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.